Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTN-001: Adherence and PK of Oral vs Vaginal Tenofovir
NCT00592124Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2008
- Primary completion
- Jul 2010
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 3
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate, tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2008; status: completed.
02
Drugs
tenofovir disoproxil fumaratetenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00592124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592124.